Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership640,840 shares
Latest Disclosed Value $ 2,294,207
Northern Trust Corp reports 3.59% increase in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 640,840 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $1,803,965 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 618,654 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 3.59% during the quarter. The current value of the position is $1,563,650 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 640,840 22,186 3.59 2,294 5.67 0.0001
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 618,654 -38,359 -5.84 2,171 1.40 0.0001
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 657,013 -44,324 -6.32 2,142 24.62 0.0001
2025-08-13 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 701,337 1,036 0.15 1,718 -63.22 0.0002
2025-05-13 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 700,301 37,149 5.60 4,671 -43.96 0.0007
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 663,152 82,316 14.17 8,336 -22.31 0.0012
2024-11-13 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 580,836 -7,761 -1.32 10,728 -15.34 0.0018
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 588,597 -21,440 -3.51 12,672 -22.89 0.0021
2024-05-14 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 610,037 -18,668 -2.97 16,434 -12.78 0.0028
2024-02-13 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 628,705 45,810 7.86 18,842 57.77 0.0034
2023-11-13 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 582,895 9,097 1.59 11,944 4.75 0.0023
2023-08-11 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 573,798 26,692 4.88 11,401 21.66 0.0022
2023-05-15 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 547,106 5,803 1.07 9,372 -11.54 0.0019
2023-02-13 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 541,303 112,618 26.27 10,593 54.82 0.0022
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 428,685 -2,562 -0.59 6,842 15.32 0.0016
2022-08-12 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 431,247 20,791 5.07 5,933 -8.86 0.0013
2022-05-13 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 410,456 -1,624 -0.39 6,510 -27.63 0.0011
2022-02-08 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 412,080 -2,538 -0.61 8,996 -27.42 0.0015
2021-11-15 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 414,618 -13,986 -3.26 12,394 -34.71 0.0022
2021-08-13 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 428,604 3,954 0.93 18,983 0.75 0.0033
2021-05-12 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 424,650 14,843 3.62 18,842 -16.16 0.0035
2021-02-11 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 409,807 -2,188 -0.53 22,474 138.60 0.0044
2020-11-16 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 411,995 -22,151 -5.10 9,419 3.65 0.0021
2020-08-14 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 434,146 23,065 5.61 9,087 58.45 0.0022
2020-05-14 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 411,081 53,141 14.85 5,735 -29.60 0.0016
2020-02-14 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 357,940 -11,796 -3.19 8,146 89.13 0.0018
2019-11-13 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 369,736 61,462 19.94 4,307 -6.86 0.0010
2019-08-13 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 308,274 2,784 0.91 4,624 -13.72 0.0011
2019-05-13 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 305,490 18,170 6.32 5,359 25.86 0.0013
2019-02-12 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 287,320 14,470 5.30 4,258 -36.62 0.0012
2018-11-14 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 272,850 33,814 14.15 6,718 43.15 0.0016
2018-09-18 2018-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 239,036 205,938 622.21 4,693 656.94 0.0012
2018-08-14 2018-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 223,796 190,698 4,394
2018-05-09 2018-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 33,098 -36,240 -52.27 620 242.54 0.0002
2018-02-14 2017-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 69,338 42,950 162.76 181 285.11 0.0000
2017-11-13 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 26,388 0 0.00 47 -6.00 0.0000
2017-08-11 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 26,388 -155,525 -85.49 50 -86.26 0.0000
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 181,913 1,696 0.94 364 -66.88 0.0001
2017-02-13 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 180,217 -9,919 -5.22 1,099 -39.01 0.0003
2016-11-09 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 190,136 7,181 3.93 1,802 32.40 0.0006
2016-08-12 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 182,955 162,996 816.65 1,361 819.59 0.0004
2016-08-19 2016-03-31 13F/A-1 INOTEK PHARMACEUTICALS COM 45780V102 19,959 1,446 7.81 148 -29.52 0.0000
2016-05-13 2016-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 19,959 148
2016-02-12 2015-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 18,513 0 0.00 210 20.69 0.0001
2015-11-12 2015-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 18,513 18,513 0.00 174 0.0001
2015-08-13 2015-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -16,661 -100.00 0 -100.00
2015-05-14 2015-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 16,661 16,661 90 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.